awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38053495-D28C7E5C-5355-42A4-BC77-00D29F547ED7
Q38053495-D28C7E5C-5355-42A4-BC77-00D29F547ED7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38053495-D28C7E5C-5355-42A4-BC77-00D29F547ED7
Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.
P2860
Q38053495-D28C7E5C-5355-42A4-BC77-00D29F547ED7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38053495-D28C7E5C-5355-42A4-BC77-00D29F547ED7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d5fe8ddaf1653c687b5283c19776ebae66291280
P2860
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.